Literature DB >> 29537320

Pregnancy outcomes in women with polycystic ovary syndrome in two Latin American populations.

Carolina Fux-Otta1,2, Manuel Maliqueo3, Bárbara Echiburú3, Otilio Rosato2,4, Nicolás Crisosto3, Gabriel S Iraci5, Marta Fiol de Cuneo6, Paula Szafryk de Mereshian1, Teresa Sir-Petermann3.   

Abstract

Pregnancy complications and obstetric outcomes were compared in 80 Chilean (PPCOSCh) and 70 Argentinian (PPCOSAr) pregnant women. Reference groups of Chilean and Argentinian normal pregnant women from the same antenatal care units were also compared. PPCOSCh showed a higher prevalence of gestational diabetes mellitus (GDM) (OR, 2.28, 95% CI: 1.08-4.77, p = .030) and a lower prevalence of pregnancy-induced hypertension (PIH) (OR, 0.20, 95% CI: 0.07-0.54, p = .001) compared to PPCOSAr. In the normal pregnant groups, the prevalence of PIH was lower in Chilean women compared to Argentinian women (OR, 0.24, 95% CI: 0.10-0.62, p = .001). Similar to the pattern observed in the normal populations, newborns from PPCOSCh had higher birth weight and length compared with the newborns of PPCOSAr (p = .006 and .014, respectively). In conclusion, differences in pregnancy complications and obstetric outcomes between Chilean and Argentinian pregnant women with PCOS could be determined by ethnic diversity together with environmental factors of both populations. Impact Statement What is already known on this subject: The reproductive and metabolic phenotypes of women with polycystic ovary syndrome vary between different populations, which could significantly influence the obstetric and neonatal outcomes in this syndrome. What the results of this study add: Pregnant women with PCOS from two Latin American countries (Chile and Argentina) exhibit differences in the prevalence of gestational diabetes and pregnancy-induced hypertension, and in the birth weight of their newborns. What the implications are of these findings for clinical practice and/or further research: Ethnic diversity together with environmental factors are fundamental elements that must be considered in the management of pregnant women with PCOS.

Entities:  

Keywords:  Argentina; Chile; Polycystic ovary syndrome; birth weight; pregnancy complications

Mesh:

Year:  2018        PMID: 29537320     DOI: 10.1080/01443615.2017.1410532

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  5 in total

Review 1.  Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy.

Authors:  David H Abbott; Daniel A Dumesic; Jon E Levine
Journal:  Expert Rev Endocrinol Metab       Date:  2019-02-15

Review 2.  A Narrative Review of Placental Contribution to Adverse Pregnancy Outcomes in Women With Polycystic Ovary Syndrome.

Authors:  Angela S Kelley; Yolanda R Smith; Vasantha Padmanabhan
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

Review 3.  In utero Androgen Excess: A Developmental Commonality Preceding Polycystic Ovary Syndrome?

Authors:  David H Abbott; Marissa Kraynak; Daniel A Dumesic; Jon E Levine
Journal:  Front Horm Res       Date:  2019-09-09       Impact factor: 2.606

4.  Are Dietary Indices Associated with Polycystic Ovary Syndrome and Its Phenotypes? A Preliminary Study.

Authors:  Ana Cutillas-Tolín; Julián Jesús Arense-Gonzalo; Jaime Mendiola; Evdochia Adoamnei; Fuensanta Navarro-Lafuente; María Luisa Sánchez-Ferrer; María Teresa Prieto-Sánchez; Ana Carmona-Barnosi; Jesús Vioque; Alberto M Torres-Cantero
Journal:  Nutrients       Date:  2021-01-22       Impact factor: 5.717

5.  Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study.

Authors:  Romina Fornes; Johanna Simin; Minh Hanh Nguyen; Gonzalo Cruz; Nicolás Crisosto; Maartje van der Schaaf; Lars Engstrand; Nele Brusselaers
Journal:  Reprod Biol Endocrinol       Date:  2022-02-07       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.